HEPATIC CANCER STAGE I

This adverse event was reported 384 times

HEPATIC CANCER STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RANITIDINE HYDROCHLORIDE 18 0.0003
1 .ALPHA.1-PROTEINASE INHIBITOR HUMAN 1 0.0003
2 RANITIDINE 32 0.0002
3 SOFOSBUVIR 1 0.0001
4 NALTREXONE 1 0.0000
5 DIGOXIN 1 0.0000
6 ROSUVASTATIN 1 0.0000
7 SACUBITRIL AND VALSARTAN 1 0.0000
8 SILDENAFIL CITRATE 1 0.0000
9 CLONAZEPAM 1 0.0000
See all drugs enriched for association with HEPATIC CANCER STAGE I